Description of a Large Urban School-Located 2009 Pandemic H1N1 Vaccination Campaign, New York City 2009–2010
First Online: 09 February 2012 DOI:
Cite this article as: Narciso, H.E., Pathela, P., Morgenthau, B.M. et al. J Urban Health (2012) 89: 317. doi:10.1007/s11524-011-9640-z Abstract
In the spring of 2009, New York City (NYC) experienced the emergence and rapid spread of pandemic influenza A H1N1 virus (pH1N1), which had a high attack rate in children and caused many school closures. During the 2009 fall wave of pH1N1, a school-located vaccination campaign for elementary schoolchildren was conducted in order to reduce infection and transmission in the school setting, thereby reducing the impact of pH1N1 that was observed earlier in the year. In this paper, we describe the planning and outcomes of the NYC school-located vaccination campaign. We compared consent and vaccination data for three vaccination models (school nurse alone, school nurse plus contract nurse, team). Overall, >1,200 of almost 1,600 eligible schools participated, achieving 26.8% consent and 21.5% first-dose vaccination rates, which did not vary significantly by vaccination model. A total of 189,902 doses were administered during two vaccination rounds to 115,668 students at 998 schools included in the analysis; vaccination rates varied by borough, school type, and poverty level. The team model achieved vaccination of more children per day and required fewer vaccination days per school. NYC’s campaign is the largest described school-located influenza vaccination campaign to date. Despite substantial challenges, school-located vaccination is feasible in large, urban settings, and during a public health emergency.
Keywords H1N1 influenza Vaccination Elementary schoolchildren
This publication was supported by the Public Health Emergency Preparedness (PHEP) Cooperative Agreement (grant number: 5U90TP221298-08) and the Public Health Emergency Response Grant (funding opportunity number: CDC-RFA-TP09-902-H1N109) from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans.
N Engl J Med
. 2009; 360(25): 2605–2615.
Hadler JL, Konty K, McVeigh KH, et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May–June 2009.
. 2010; 5(7): e11677.
Cawley J, Hull HF, Rousculp MD. Strategies for implementing school-located influenza vaccination of children: a systematic literature review.
J Sch Health
. 2010; 80(4): 167–175.
Davis MM, King JC Jr, Moag L, Cummings G, Magder LS. Countywide school-based influenza immunization: direct and indirect impact on student absenteeism.
. 2008; 122(1): e260–5.
King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination.
N Engl J Med
. 2006; 355(24): 2523–2532.
Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly.
. 2006; 134(1): 71–78.
Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.
. 2010; 303(10): 943–950.
Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza.
N Engl J Med
. 2001; 344(12): 889–896.
Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
. 2005; 23(13): 1540–1548.
U.S. Census Bureau. American FactFinder, Fact Sheet for New York City, New York.
. Accessed May 4, 2010.
Statistical summaries—Data About Schools—New York City Department of Education.
. Accessed May 4, 2010.
NYSED:IRS: Directory of public and non-public schools and administrators in New York State. May 19, 2010.
. Accessed June 8, 2010.
Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009;58 (No. RR-10):1–8.
Myers C, Olson C, Kerker B, Thorpe L, Greene C, Farley T. Reducing health disparities in New York City: health disparities in life expectancy and death. New York, NY: New York City Department of Health and Mental Hygiene, 2010.
. Accessed July 19, 2011.
Effler PV, Chu C, He H, et al. Statewide school-located influenza vaccination program for children 5–13 years of age, Hawaii, USA.
Emerg Infect Dis
. 2010; 16(2): 244–250.
Woodruff BA, Unti L, Coyle K, Boyer-Chuanroong L. Parents’ attitudes toward school-based hepatitis B vaccination of their children.
. 1996; 98(3 Pt 1): 410–413.
Kansagra S, McGinty M, Maldin B. Cost comparison of two mass vaccination campaigns against H1N1 in New York City. December 15, 2011.
. Accessed January 9, 2012.
Carpenter LR, Lott J, Lawson BM, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system.
. 2007; 120(1): e172–8.
Talbot HK, Poehling KA, Williams JV, et al. Influenza in older adults: impact of vaccination of school children.
. 2009; 27(13): 1923–1927.
Rinchiuso-Hasselmann A, McKay RL, Williams CA, et al. Protecting the public from H1N1 through points of dispensing (PODs).
. 2011; 9(1): 13–21.
Steelfisher GK, Blendon RJ, Bekheit MM, Lubell K. The public’s response to the 2009 H1N1 influenza pandemic.
N Engl J Med. 2010: 362–e65
Community Health Survey, 2008: NYC DOHMH. EpiQuery: NYC Interactive Health Data. December 31, 2009.
. Accessed June 16, 2010.
© The New York Academy of Medicine 2012